Is this you?
Request access for Austin Clinical Research with your @austinclinicalresearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Austin Clinical Research
Unclaimed profileIndependent Site · Austin, Texas · ~1 sites
Intera lens
ICP 5Lift (cardio sample) 0.07Recruit soph 0.43
Quality Scorecard (1–100)
Overall80Recruit64Ops87Sponsor89Ther83
Performance (observed)
Historical trials
393
Completed
232
Terminated/Withdrawn
38
Completion rate
86%
Active now
117
Phase 2
121
Phase 3
213
Realized enrollment
338,821
First study year
1995
Years active
31
Match confidence
high
Enrollment velocity (inf)
10,930
Therapeutic
Areas
Retinal diseases (macular degeneration, diabetic retinopathy, retinal vein occlusion, uveitis, MacTel)
Specialties
Ophthalmology/Retina: AMD, diabetic retinopathy, uveitis, dry eye, glaucoma
Breadth (conditions)
472
Languages
English
States
Texas
Recruitment (web observed)
Trial Finder
Yes
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Good (clinical focus, investigator bios)
Capability notes
Moderate; independent research-focused retina site; no-cost care for qualified participants
Relationships
Sponsors
Pfizer; AbbVie; Hoffmann-La Roche; Eli Lilly and Company; Boehringer Ingelheim; Gilead Sciences
CROs
Clinipace Worldwide; Croma-Pharma GmbH; ICON Clinical Research; IQVIA Pvt. Ltd; MacroGenics; PPD Development, LP
Owner / parent
Privately held; founded 2021; independent research-only facility (9 employees)
Acquisitions
N (previously part of Retina Research Center)
Expansion
Founded 2021 (independent spinoff)
Capacity & people
Investigators
—
Coordinators
—
CEO
Ivana Gunderson, BS (Director/Founder)
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
igunderson@retinaresearchcenter.net; info@austinclinicalresearch.com
Tech & DCT
Builds tech
Unknown
DCT / decentralized
N - single Austin location
Tech stack
Unknown
Recruiting visible
Y
Notes
Single-site independent retina research center founded 2021 by Ivana Gunderson (15+ years research exp., prior director Retina Research Center). 3 board-certified investigators (Makkouk, Loose, Whiteside). Unique model: research-only (no clinical practice). CTGOV signal: 11 recruiting trials across 1 location, Texas
Recommendation features (sample indication)
Ind fit 0.12Liftability 0.07Overall80
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.